Abivax shares fall below their €75.50 floor and drop 11% in one week
The Paris-based biotech specialising in inflammatory diseases falls mid-session, in a market trending lower across the euro zone. The move pushes a technical level from support to resistance and places the stock near the bottom of its index ranking.
The lowest point of the last 30 sessions has been broken, and the three moving averages are now above the price
Abivax shares fell 3.61% to €73.35 during the session, compared with €76.10 the previous day. The stock broke below its lowest point of the last 30 sessions, at €75.50, which now becomes resistance, and it has lost 11.09% over one week.
The price is below the 20-day moving average (a gap of 6.55%), the 50-day moving average (10.18%) and the 200-day moving average (24.72%), with an RSI at 37, which has not yet reached the oversold zone.
Among the SBF 120 stocks, Abivax is one of the largest decliners of the session, while the index is down 1.31%.
The dual listing on Euronext Paris and the Nasdaq, where the two lines move almost in unison, links the stock to the American sessions: Wall Street closed Thursday sharply lower, with the Nasdaq down 2.25%, and the VIX rose to 29.26 during the session.
Five funds together hold 5.67% of the capital sold short, a slight increase over one month
The net short positions declared on Abivax reach 5.67% of the capital, held by five funds according to the declarations consulted, the latest dating from November 18. This level is up 0.15 points over thirty days, after 5.52% one month earlier.
The increase is modest, but it occurs on a stock that has already lost nearly 29% over three months: a stock of bearish bets of this size corresponds to institutional investors positioned against the stock or seeking to hedge an exposure.
The figure says nothing about the precise motivations of these funds, and it should be monitored over time rather than based on a single session. The €63.10 level is the nearest support threshold mentioned in the indicators, roughly 14% below the current price.